Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Arcturus Therapeutics Holdings Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 113
- −2 vs. Q3 2022
- Shares held
- 22.6M
- +591.1K (+2.7%) vs. Q3 2022
- Total value
- $383.9M
- +$57.6M (+17.7%) vs. Q3 2022
- New holders
- 19
- 38 more added
- Sold out
- 21
- 36 more reduced
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 124 | $187.3M |
| Q4 2025 | 121 | $145.1M |
| Q3 2025 | 137 | $476.8M |
| Q2 2025 | 145 | $336.3M |
| Q1 2025 | 147 | $282.9M |
| Q4 2024 | 149 | $452.5M |
| Q3 2024 | 164 | $609.3M |
| Q2 2024 | 171 | $640.0M |
| Q1 2024 | 179 | $918.7M |
| Q4 2023 | 166 | $801.6M |
| Q3 2023 | 147 | $643.1M |
| Q2 2023 | 144 | $677.6M |
| Q1 2023 | 124 | $557.9M |
| Q4 2022 | 113 | $383.9M |
| Q3 2022 | 117 | $328.1M |
| Q2 2022 | 128 | $353.6M |
| Q1 2022 | 129 | $578.1M |
| Q4 2021 | 139 | $736.2M |
| Q3 2021 | 157 | $909.0M |
| Q2 2021 | 139 | $694.0M |
| Q1 2021 | 162 | $776.0M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Arcturus Therapeutics Holdings Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 343,177 | $5.82M | 0.00% | −2,974−0.9% | Reduced |
| Geode Capital Management, LLC | 449,939 | $7.63M | 0.00% | +33,148+8.0% | Added |
| Bank of America Corp | 685,954 | $11.6M | 0.00% | +577,968+535.2% | Added |
| Woodline Partners LP | 752,331 | $12.8M | 0.18% | −125,193−14.3% | Reduced |
| FMR LLC | 910,243 | $15.4M | 0.00% | −44,082−4.6% | Reduced |
| Balyasny Asset Management LLC | 1,004,235 | $17.0M | 0.06% | +664,852+195.9% | Added |
| Nikko Asset Management Americas, Inc. | 1,449,060 | $24.6M | 0.35% | −10,355−0.7% | Reduced |
| Sumitomo Mitsui Trust Holdings, Inc. | 1,449,060 | $24.6M | 0.02% | −10,355−0.7% | Reduced |
| Vanguard Group Inc | 1,450,425 | $24.6M | 0.00% | +113,607+8.5% | Added |
| BlackRock Inc. | 1,884,885 | $32.0M | 0.00% | −75,704−3.9% | Reduced |
| ARK Investment Management LLCSuperinvestorARK Invest | 2,012,429 | $34.1M | 0.30% | −169,274−7.8% | Reduced |
| State Street Corp | 2,257,846 | $38.3M | 0.00% | −472,616−17.3% | Reduced |
| Federated Hermes, Inc. | 4,239,554 | $71.9M | 0.20% | +672,057+18.8% | Added |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −130,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −75,047−100.0% | Sold out |
| Shelton Capital Management | 0 | $0 | 0.00% | −45,300−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −41,567−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −26,680−100.0% | Sold out |
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −24,948−100.0% | Sold out |
| State Board of Administration of Florida Retirement System | 0 | $0 | 0.00% | −16,711−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −14,481−100.0% | Sold out |
| E Fund Management Co., Ltd. | 0 | $0 | 0.00% | −12,713−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −12,417−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −11,940−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −11,399−100.0% | Sold out |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −7,843−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| High Net Worth Advisory Group LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −340−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | 0 | Sold out |
| First Manhattan Co | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −15−100.0% | Sold out |
| ACT Capital Management, LLC | – | – | – | – | Not filed |
| Wipfli Financial Advisors LLC, | – | – | – | – | Not filed |